Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Work In Process (2018 - 2025)

TransMedics (TMDX) has 8 years of Work In Process data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Work In Process fell 38.73% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 38.73%, while the annual FY2025 figure was $2.0 million, 38.73% down from the prior year.
  • Work In Process reached $2.0 million in Q4 2025 per TMDX's latest filing, up from $1.6 million in the prior quarter.
  • Across five years, Work In Process topped out at $4.9 million in Q3 2024 and bottomed at $1.3 million in Q2 2021.
  • Average Work In Process over 5 years is $2.7 million, with a median of $2.4 million recorded in 2022.
  • Peak YoY movement for Work In Process: soared 102.88% in 2023, then crashed 66.52% in 2025.
  • A 5-year view of Work In Process shows it stood at $1.9 million in 2021, then decreased by 2.9% to $1.9 million in 2022, then skyrocketed by 102.88% to $3.8 million in 2023, then fell by 13.98% to $3.3 million in 2024, then crashed by 38.73% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $2.0 million in Q4 2025, $1.6 million in Q3 2025, and $3.9 million in Q2 2025.